Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Yamanaka, Saori Kosugi, E. Konishi (2007)
Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement LevelsJournal of Virology, 82
Michael Diamond, Michael Diamond, T. Roberts, D. Edgil, B. Lu, Joel Ernst, Joel Ernst, E. Harris (2000)
Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma InterferonsJournal of Virology, 74
J. Ashour, Juliet Morrison, Maudry Laurent-Rolle, Alan Belicha-Villanueva, C. Plumlee, Dabeiba Bernal-Rubio, K. Williams, E. Harris, A. Fernández-Sesma, C. Schindler, A. García-Sastre (2010)
Mouse STAT2 restricts early dengue virus replication.Cell host & microbe, 8 5
A. Rothman, I. Kurane, C. Lai, M. Bray, B. Falgout, R. Men, F. Ennis (1993)
Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytesJournal of Virology, 67
P. Russell, S. Udomsakdi, S. Halstead (1967)
Antibody response in dengue and dengue hemorrhagic fever.Japanese journal of medical science & biology, 20 Suppl
E. Borden, G. Sen, G. Uzé, R. Silverman, R. Ransohoff, G. Foster, G. Stark (2007)
Interferons at age 50: past, current and future impact on biomedicineNature Reviews. Drug Discovery, 6
B. Sierra, G. Kourí, M. Guzmán (2006)
Race: a risk factor for dengue hemorrhagic feverArchives of Virology, 152
P. Chiewsilp, R. Scott, N. Bhamarapravati (1981)
Histocompatibility antigens and dengue hemorrhagic fever.The American journal of tropical medicine and hygiene, 30 5
I Zivna, S Green, DW Vaughn, S Kalayanarooj, HA Stephens, D Chandanayingyong (2002)
T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severityJ Immunol, 168
Federico Narvaez, G. Gutiérrez, M. Pérez, Douglas Elizondo, A. Núnez, A. Balmaseda, E. Harris (2011)
Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease SeverityPLoS Neglected Tropical Diseases, 5
R. Rico-Hesse, L. Harrison, R. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Bóshell, Maria Mesa, R. Nogueira, A. Rosa (1997)
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas.Virology, 230 2
H. Stephens, H. Stephens, R. Klaythong, M. Sirikong, D. Vaughn, S. Green, S. Kalayanarooj, T. Endy, D. Libraty, A. Nisalak, B. Innis, A. Rothman, F. Ennis, D. Chandanayingyong (2002)
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.Tissue antigens, 60 4
E. Hayes, D. Gubler (1992)
Dengue and dengue hemorrhagic fever.Clinical microbiology reviews, 11 3
A. Balmaseda, K. Standish, J. Mercado, Juan Matute, Y. Téllez, S. Saborío, S. Hammond, A. Núnez, W. Avilés, M. Henn, E. Holmes, A. Gordon, J. Coloma, G. Kuan, E. Harris (2010)
Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua.The Journal of infectious diseases, 201 1
S. Green, D. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, A. Rothman, F. Ennis (1999)
Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severityJournal of Medical Virology, 59
B. Murphy, S. Whitehead (2011)
Immune response to dengue virus and prospects for a vaccine.Annual review of immunology, 29
W. Messer, D. Gubler, E. Harris, K. Sivananthan, A. Silva (2003)
Emergence and Global Spread of a Dengue Serotype 3, Subtype III VirusEmerging Infectious Diseases, 9
H. Loke, D. Bethell, C. Phuong, Minh Dung, J. Schneider, N. White, N. Day, J. Farrar, A. Hill (2001)
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?The Journal of infectious diseases, 184 11
Rebecca Littaua, I. Kurane, F. Ennis
Antibody-dependent Enhancement of Dengue Human Igg Fc Receptor Ii Mediates
K. Boonnak, Kaitlyn Dambach, G. Donofrio, B. Tassaneetrithep, M. Marovich (2010)
Cell Type Specificity and Host Genetic Polymorphisms Influence Antibody-Dependent Enhancement of Dengue Virus InfectionJournal of Virology, 85
A. Rothman (2011)
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine stormsNature Reviews Immunology, 11
Alison Johnson, J. Roehrig (1999)
New Mouse Model for Dengue Virus Vaccine TestingJournal of Virology, 73
S. Thein, M. Aung, T. Shwe, M. Aye, A. Zaw, Kathy Aye, K. Aye, J. Aaskov (1997)
Risk factors in dengue shock syndrome.The American journal of tropical medicine and hygiene, 56 5
A. Goncalvez, R. Engle, M. Claire, R. Purcell, C. Lai (2007)
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for preventionProceedings of the National Academy of Sciences, 104
C. Welsch, S. Zeuzem (2009)
RNA-binding activity of hepatitis C virus NS4B: a novel target for small molecule inhibitors.Gastroenterology, 137 6
Ling-Jun Ho, L. Hung, Chun-Yi Weng, Wan‐Lin Wu, P. Chou, Yi-Ling Lin, D. Chang, T. Tai, J. Lai (2005)
Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.Journal of immunology, 174 12
S. Vejbaesya, P. Luangtrakool, K. Luangtrakool, S. Kalayanarooj, D. Vaughn, T. Endy, M. Mammen, S. Green, D. Libraty, F. Ennis, A. Rothman, H. Stephens (2009)
TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais.The Journal of infectious diseases, 199 10
J. Mota, R. Rico-Hesse (2009)
Humanized Mice Show Clinical Signs of Dengue Fever according to Infecting Virus GenotypeJournal of Virology, 83
B. Fredericksen, M. Gale (2006)
West Nile Virus Evades Activation of Interferon Regulatory Factor 3 through RIG-I-Dependent and -Independent Pathways without Antagonizing Host Defense SignalingJournal of Virology, 80
D. Vaughn, S. Green, S. Kalayanarooj, B. Innis, S. Nimmannitya, S. Suntayakorn, T. Endy, B. Raengsakulrach, A. Rothman, F. Ennis, A. Nisalak (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.The Journal of infectious diseases, 181 1
W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul, Patricia Fitton, Sirijitt Vasanawathana, W. Limpitikul, C. Puttikhunt, Carolyn Edwards, T. Duangchinda, Sunpetchuda Supasa, Kriangkrai Chawansuntati, P. Malasit, J. Mongkolsapaya, G. Screaton (2010)
Cross-Reacting Antibodies Enhance Dengue Virus Infection in HumansScience, 328
M. Diamond, M. Diamond, E. Harris (2001)
Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.Virology, 289 2
J. Rodríguez-Madoz, Dabeiba Bernal-Rubio, D. Kaminski, K. Boyd, A. Fernández-Sesma (2010)
Dengue Virus Inhibits the Production of Type I Interferon in Primary Human Dendritic CellsJournal of Virology, 84
(2009)
Dengue, guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization
W. Messer, U. Vitarana, Jayanthi Elvtigala, K. Sivananthan, L. Preethimala, R. Ramesh, D. Gubler, N. Withana, A. Silva (2002)
Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever.The American journal of tropical medicine and hygiene, 66 6
S. Green, I. Kurane, S. Pincus, E. Paoletti, F. Ennis (1997)
Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones.Virology, 234 2
R Littaua, I Kurane, FA Ennis (1990)
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infectionJ Immunol, 144
I. Kurane, B. Innis, S. Nimmannitya, A. Nisalak, A. Meager, Jurand Janus, F. Ennis (1991)
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.The Journal of clinical investigation, 88 5
A. Rothman, Ichiro Kurane, Francis Ennis (1996)
Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virusJournal of Virology, 70
Justin Anderson, R. Rico-Hesse (2006)
Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus.The American journal of tropical medicine and hygiene, 75 5
A. Spaulding, I. Kurane, F. Ennis, A. Rothman (1999)
Analysis of Murine CD8+ T-Cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-Reactivity and Influence of Infecting SerotypeJournal of Virology, 73
J. Rodríguez-Madoz, Alan Belicha-Villanueva, Dabeiba Bernal-Rubio, J. Ashour, Juan Ayllon, A. Fernández-Sesma (2010)
Inhibition of the Type I Interferon Response in Human Dendritic Cells by Dengue Virus Infection Requires a Catalytically Active NS2B3 ComplexJournal of Virology, 84
Meleri Jones, A. Davidson, L. Hibbert, Petra Gruenwald, J. Schlaak, S. Ball, G. Foster, M. Jacobs (2005)
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 ExpressionJournal of Virology, 79
B. Murgue, C. Roche, E. Chungue, X. Deparis (2000)
Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996–1997 dengue‐2 outbreak in French PolynesiaJournal of Medical Virology, 60
A. Limón-Flores, M. Pérez-Tapia, I. Estrada-García, Gilberto Vaughan, A. Escobar-Gutiérrez, J. Calderón-Amador, S. Herrera-Rodríguez, Adriana Brizuela-Garcia, Monica Heras-Chavarría, A. Flores-Langarica, L. Cedillo-Barrón, L. Flores-Romo (2005)
Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cellsInternational Journal of Experimental Pathology, 86
A. Sabin (1952)
Research on dengue during World War II.The American journal of tropical medicine and hygiene, 1 1
Anne Tuiskunen, V. Monteil, S. Plumet, L. Boubis, M. Wahlström, V. Duong, P. Buchy, Å. Lundkvist, H. Tolou, I. Leparc-Goffart (2011)
Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndromeArchives of Virology, 156
A. Mathew, I. Kurane, A. Rothman, Lingling Zeng, M. Brinton, F. Ennis (1996)
Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.The Journal of clinical investigation, 98 7
J. Mackenzie, Malcolm Jones, P. Young, P. Young (1996)
Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication.Virology, 220 1
J. Ashour, Maudry Laurent-Rolle, P. Shi, A. García-Sastre (2009)
NS5 of Dengue Virus Mediates STAT2 Binding and DegradationJournal of Virology, 83
J. Muñoz-Jordán, Maudry Laurent-Rolle, J. Ashour, L. Martínez-Sobrido, Mundrigi Ashok, W. Lipkin, A. García-Sastre (2005)
Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of FlavivirusesJournal of Virology, 79
Claribel Marmol (2009)
The Mount Sinai School of Medicine
A. Rothman, I. Kurane, Y. Zhang, C. Lai, F. Ennis (1989)
Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteinsJournal of Virology, 63
Kala Jessie, Mun Yik Fong, S. Devi, Sai Kit Lam, K. Thong Wong (2004)
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization.The Journal of infectious diseases, 189 8
Tran Chau, N. Quyen, T. Thuy, N. Tuan, Dang Hoang, N. Dung, L. Lien, N. Quy, N. Hieu, Lu Hieu, T. Hien, N. Hung, J. Farrar, C. Simmons (2008)
Dengue in Vietnamese infants--results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity.The Journal of infectious diseases, 198 4
G. Malavige, G. Malavige, T. Rostron, L. Rohanachandra, S. Jayaratne, N. Fernando, Aruna Silva, M. Liyanage, G. Ogg, G. Ogg (2011)
HLA Class I and Class II Associations in Dengue Viral Infections in a Sri Lankan PopulationPLoS ONE, 6
T. Endy, I. Yoon, M. Mammen (2010)
Prospective cohort studies of dengue viral transmission and severity of disease.Current topics in microbiology and immunology, 338
D. Libraty, T. Endy, H. Houng, S. Green, S. Kalayanarooj, S. Suntayakorn, Wanya Chansiriwongs, D. Vaughn, A. Nisalak, F. Ennis, A. Rothman (2002)
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.The Journal of infectious diseases, 185 9
A. Srikiatkhachorn, A. Rothman, R. Gibbons, N. Sittisombut, P. Malasit, F. Ennis, S. Nimmannitya, S. Kalayanarooj (2011)
Dengue--how best to classify it.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53 6
T. Pierson, Qing Xu, Steevenson Nelson, Theodore Oliphant, G. Nybakken, D. Fremont, M. Diamond (2007)
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.Cell host & microbe, 1 2
A. Mathew, I. Kurane, S. Green, H. Stephens, D. Vaughn, S. Kalayanarooj, S. Suntayakorn, D. Chandanayingyong, F. Ennis, A. Rothman (1998)
Predominance of HLA-Restricted Cytotoxic T-Lymphocyte Responses to Serotype-Cross-Reactive Epitopes on Nonstructural Proteins following Natural Secondary Dengue Virus InfectionJournal of Virology, 72
K. Boonnak, B. Slike, T. Burgess, R. Mason, Shuenn-Jue Wu, Peifang Sun, K. Porter, I. Rudiman, Djoko Yuwono, P. Puthavathana, M. Marovich (2008)
Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus InfectionJournal of Virology, 82
S. Green, D. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B. Innis, I. Kurane, A. Rothman, F. Ennis (1999)
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity.The Journal of infectious diseases, 179 4
Lin Wang, Rong-Fu Chen, Jien-Wei Liu, Ing-Kit Lee, Chiu-Ping Lee, H. Kuo, Shau-ku Huang, Kuender Yang (2011)
DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune AugmentationPLoS Neglected Tropical Diseases, 5
Izabela Rodenhuis-Zybert, H. Schaar, Júlia Voorham, Heidi Ende-Metselaar, H. Lei, J. Wilschut, J. Smit (2010)
Immature Dengue Virus: A Veiled Pathogen?PLoS Pathogens, 6
J. Muñoz-Jordán, G. Sánchez-Burgos, Maudry Laurent-Rolle, A. García-Sastre (2003)
Inhibition of interferon signaling by dengue virusProceedings of the National Academy of Sciences of the United States of America, 100
Dengue virus is a worldwide health problem, with billions of people at risk annually. Dengue virus causes a spectrum of diseases, namely dengue fever, dengue hemorrhagic fever and dengue shock syndrome with the latter two being linked to death. Understanding how dengue is able to evade the immune system and cause enhanced severity of disease is the main topics of interest in the Fernandez-Sesma laboratory at Mount Sinai School of Medicine. Using primary human immune cells, our group investigates the contribution of dengue virus-specific proteins to the evasion of innate immunity by this virus and the host factors that the virus interacts with in order to evade immune recognition and to establish infection in humans. Here, we review recent findings from our group as well as published data from other groups regarding immune modulation by dengue virus.
Immunologic Research – Springer Journals
Published: May 9, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.